Aytu BioPharma, Inc.
USD2.14
-0.05 (-2.28%)
CEO
Joshua R. Disbrow
IPO Date
2008-09-25
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$2.16
Prev. Close
$2.19
Day Low
$2.12
Day High
$2.20
52W Low
$1.65
52W High
$3.07
Market Cap
$0.02B
Volume
0.04M
| -1.0 |
| 30 Jun 2023 | FY | 62.0% | -15.9% | -43.3% | -12.4% | 0.77 | 1.06 | -0.3 |
| 30 Jun 2022 | FY | 52.0% | -112.5% | -245.5% | -79.0% | 0.41 | 0.93 | -0.2 |
| 30 Jun 2021 | FY | 44.5% | -88.8% | -42.4% | -21.9% | 0.23 | 0.96 | -1.4 |
| 30 Jun 2020 | FY | 70.0% | -49.3% | -14.3% | -8.9% | 0.02 | 2.62 | -4.8 |
| 30 Jun 2019 | FY | 69.9% | -644.3% | -665.5% | -135.8% | 0.00 | 2.87 | -0.3 |
| 30 Jun 2018 | FY | 44.0% | -278.4% | -75.9% | -48.4% | 0.00 | 2.79 | -0.3 |
| 30 Jun 2017 | FY | 56.0% | -698.7% | -562.7% | -150.1% | 0.00 | 0.84 | -0.2 |
| 30 Jun 2016 | FY | 62.6% | -1099.7% | -279.4% | -115.8% | 0.00 | 1.00 | -0.3 |
| -0.6 |
| 30 Sept 2025 | Q1 | 66.1% | 14.1% | 8.5% | 1.6% | 1.17 | 1.23 | 2.3 |
| 30 Jun 2025 | Q4 | 67.8% | -130.9% | -104.5% | -16.0% | 1.21 | 1.26 | -0.2 |
| 31 Mar 2025 | Q3 | 69.4% | 21.6% | 11.4% | 3.2% | 0.65 | 1.03 | 0.5 |
| 31 Dec 2024 | Q2 | 66.5% | 4.9% | 2.6% | 0.7% | 0.56 | 0.98 | 3.3 |
| 30 Sept 2024 | Q1 | 72.3% | 8.9% | 4.9% | 1.3% | 0.61 | 0.99 | 2.9 |
| 30 Jun 2024 | Q4 | 66.2% | -25.7% | -16.7% | -3.9% | 0.59 | 0.99 | -0.9 |
| 31 Mar 2024 | Q3 | 73.9% | -20.6% | -9.4% | -2.2% | 0.73 | 0.85 | -1.4 |
| 31 Dec 2023 | Q2 | 77.9% | -1.2% | -0.7% | -0.2% | 0.56 | 1.11 | -17.8 |